Notably, intrapatient concordance was also found for the clinically relevant target genes ERBB2 and EGFR, including in comparison with the primary tumor of one patient with ERBB2 amplification (9 additional copies in the primary and 17 and 18 additional copies in the two metastases). This evidence concerns the gene EGFR and neoplasm.